中国全科医学
中國全科醫學
중국전과의학
CHINESE GENERAL PRACTICE
2014年
29期
3505-3507
,共3页
李东%夏晨梅%张忠臣%颜海帆
李東%夏晨梅%張忠臣%顏海帆
리동%하신매%장충신%안해범
肝肾综合征%预后%血浆尾加压素Ⅱ
肝腎綜閤徵%預後%血漿尾加壓素Ⅱ
간신종합정%예후%혈장미가압소Ⅱ
Hepatorenal syndrome%Prognosis%Plasma urotensin Ⅱ
目的:探讨血浆尾加压素Ⅱ与2型肝肾综合征( HRS)患者预后的关系。方法选取2009年1月-2013年1月在温岭市第一人民医院住院、已明确诊断为2型HRS的患者78例,患者入院后即开始随访,随访时间为3个月。若患者在随访期间死亡,则纳入死亡组,否则纳入存活组。对比分析两组患者性别、年龄、合并症、终末期肝病模型( MELD)评分、实验室检查〔包括丙氨酸氨基转移酶( ALT)、总胆红素、清蛋白、血肌酐、白细胞计数、血红蛋白、血小板计数、C反应蛋白、血浆尾加压素Ⅱ及国际标准化比率( INR)〕等。采用时间依存风险比例模型探讨2型HRS患者预后的影响因素。结果随访3个月时,存活组31例,死亡组47例。两组性别、年龄、消化道出血、肝性脑病、脓毒症、ALT、清蛋白、白细胞计数、血红蛋白、血小板计数、C反应蛋白和INR比较,差异均无统计学意义(P>0.05)。死亡组总胆红素、血肌酐、血浆尾加压素Ⅱ和MELD评分均高于存活组(P<0.01)。时间依存风险比例模型结果显示,血浆尾加压素Ⅱ、总胆红素和MELD评分均是2型HRS患者预后的影响因素( P<0.05)。结论血浆尾加压素Ⅱ升高提示2型HRS患者预后不良。
目的:探討血漿尾加壓素Ⅱ與2型肝腎綜閤徵( HRS)患者預後的關繫。方法選取2009年1月-2013年1月在溫嶺市第一人民醫院住院、已明確診斷為2型HRS的患者78例,患者入院後即開始隨訪,隨訪時間為3箇月。若患者在隨訪期間死亡,則納入死亡組,否則納入存活組。對比分析兩組患者性彆、年齡、閤併癥、終末期肝病模型( MELD)評分、實驗室檢查〔包括丙氨痠氨基轉移酶( ALT)、總膽紅素、清蛋白、血肌酐、白細胞計數、血紅蛋白、血小闆計數、C反應蛋白、血漿尾加壓素Ⅱ及國際標準化比率( INR)〕等。採用時間依存風險比例模型探討2型HRS患者預後的影響因素。結果隨訪3箇月時,存活組31例,死亡組47例。兩組性彆、年齡、消化道齣血、肝性腦病、膿毒癥、ALT、清蛋白、白細胞計數、血紅蛋白、血小闆計數、C反應蛋白和INR比較,差異均無統計學意義(P>0.05)。死亡組總膽紅素、血肌酐、血漿尾加壓素Ⅱ和MELD評分均高于存活組(P<0.01)。時間依存風險比例模型結果顯示,血漿尾加壓素Ⅱ、總膽紅素和MELD評分均是2型HRS患者預後的影響因素( P<0.05)。結論血漿尾加壓素Ⅱ升高提示2型HRS患者預後不良。
목적:탐토혈장미가압소Ⅱ여2형간신종합정( HRS)환자예후적관계。방법선취2009년1월-2013년1월재온령시제일인민의원주원、이명학진단위2형HRS적환자78례,환자입원후즉개시수방,수방시간위3개월。약환자재수방기간사망,칙납입사망조,부칙납입존활조。대비분석량조환자성별、년령、합병증、종말기간병모형( MELD)평분、실험실검사〔포괄병안산안기전이매( ALT)、총담홍소、청단백、혈기항、백세포계수、혈홍단백、혈소판계수、C반응단백、혈장미가압소Ⅱ급국제표준화비솔( INR)〕등。채용시간의존풍험비례모형탐토2형HRS환자예후적영향인소。결과수방3개월시,존활조31례,사망조47례。량조성별、년령、소화도출혈、간성뇌병、농독증、ALT、청단백、백세포계수、혈홍단백、혈소판계수、C반응단백화INR비교,차이균무통계학의의(P>0.05)。사망조총담홍소、혈기항、혈장미가압소Ⅱ화MELD평분균고우존활조(P<0.01)。시간의존풍험비례모형결과현시,혈장미가압소Ⅱ、총담홍소화MELD평분균시2형HRS환자예후적영향인소( P<0.05)。결론혈장미가압소Ⅱ승고제시2형HRS환자예후불량。
Objective To explore the relationship between plasma urotensinⅡand the prognosis of patients with type 2 hepatorenal syndrome(HRS). Methods From January 2009 to January 2013,in the First People's Hospital of Wenling,78 type 2 HRS patients had follow-up after admission,for 3 months. The patients who died during follow-up were enrolled in death group,those who did not die were enrolled in survival group. Patients' gender,age,complications,scores of model of end-stage liver disease(MELD),laboratory examinations were contrasted. The laboratory examinations included ALT,total bilirubin(TBiL),albumin(AL),creatinine(Cr),white blood cell(WBC),hemoglobin,platelet,C -reactive protein ( CRP),urotensin Ⅱ and international normalized ratio( INR). To explore the factors influencing type 2 HRS patients' prog-noses,time-dependent proportional hazard model was used. Results After 3 months follow-up,there were 31 patients in survival group,47 in death group. There was no significant difference in gender,age,gastrointestinal bleeding,hepatic en-cephalopathy,sepsis,ALT,AL,WBC,hemoglobin,platelets,CRP,INR between 2 groups(P>0. 05). TBiL,Cr,uro-tensin Ⅱ,MELD scores were higher in death group than in survival group ( P<0. 01 ). Time-dependent proportional hazard model showed that urotensin Ⅱ,TBiL,MELD scores were the factors influencing the prognoses of type 2 HRS patients( P<0. 05). Conclusion Elevated urotensin Ⅱ suggests poor prognoses of type 2 HRS patients.